세계의 신규 정신건강 디바이스 및 플랫폼 시장 예측 : 제품 유형, 치료법, 연령층, 기술, 용도, 최종 사용자, 지역별 세계 분석(-2032년)

According to Stratistics MRC, the Global Emerging Mental Health Devices and Platforms Market is accounted for $5.1 billion in 2025 and is expected to reach $17.4 billion by 2032 growing at a CAGR of 19.3% during the forecast period. Emerging mental health devices and platforms refer to advanced digital tools and technologies aimed at diagnosing, monitoring, and managing mental health conditions. These include wearable biosensors, neurostimulation devices, AI-powered chatbots, mobile apps, and virtual therapy platforms. They enable real-time mental state tracking, remote consultations, and personalized treatment recommendations. Spurred by increased mental health awareness and telehealth adoption, these innovations are revolutionizing mental healthcare delivery, improving accessibility, reducing stigma, and promoting proactive emotional well-being across diverse populations.

According to the National Alliance on Mental Illness (2023), with 1 in 5 U.S. adults experiencing mental illness, there is a growing emphasis on developing AI-powered tools that can provide real-time support and monitoring.

Market Dynamics:

Driver:

Increasing adoption of telehealth services

The rapid adoption of telehealth services is significantly driving the emerging mental health devices and platforms market. With growing demand for accessible and convenient mental health support, digital consultations and app-based therapies are gaining widespread traction. Telehealth breaks geographical barriers, reduces stigma, and enables real-time patient-therapist interaction. Government support, insurance coverage expansions, and evolving patient preferences toward virtual care are further accelerating market adoption across both developed and developing regions, creating sustained momentum for digital mental health innovation.

Restraint:

High device development and deployment costs

High costs associated with developing and deploying mental health devices pose a major restraint to market growth. Designing clinically validated, user-friendly hardware-such as neurostimulators and wearable biosensors-requires substantial R&D investment and regulatory compliance. Startups and small companies often struggle with limited funding and production scalability. Additionally, ensuring integration with telehealth platforms and data security protocols further adds to development complexity, slowing market penetration, particularly in resource-constrained environments or among underserved healthcare providers.

Opportunity:

Growing demand for remote mental health monitoring

The growing demand for remote mental health monitoring represents a major opportunity in the market. Wearables and mobile applications capable of tracking mood, sleep, heart rate variability, and stress levels in real-time are gaining popularity among patients and clinicians. These tools allow early intervention, personalized care, and continuous support beyond clinical settings. As awareness of mental well-being increases and technology adoption rises, especially among younger populations, remote monitoring solutions are poised to become central to proactive mental healthcare.

Threat:

Regulatory hurdles for digital therapeutics

Strict regulatory frameworks for digital therapeutics present a critical threat to the emerging mental health devices and platforms market. Gaining approval from agencies such as the FDA or EMA requires rigorous clinical trials, data privacy safeguards, and compliance with evolving telehealth laws. These challenges delay product launches and increase go-to-market costs. Moreover, uncertainty in reimbursement policies and classification of digital therapies creates ambiguity for developers, discouraging innovation and limiting the availability of clinically proven digital mental health solutions.

Covid-19 Impact:

The COVID-19 pandemic dramatically accelerated the use of digital mental health solutions due to rising psychological distress and limited in-person care access. Lockdowns and isolation drove demand for virtual therapy platforms, mental health apps, and remote monitoring tools. The crisis validated the scalability of digital therapeutics and increased funding toward mental health tech startups. As hybrid care models become the norm, COVID-19 has reshaped the mental healthcare landscape, solidifying digital platforms as essential components of long-term mental health strategies.

The platforms segment is expected to be the largest during the forecast period

The platforms segment is expected to account for the largest market share during the forecast period, owing to widespread adoption of app-based therapies, virtual consultations, and mental wellness programs. These platforms offer scalable solutions that are accessible, customizable, and cost-effective for both patients and providers. Features like guided meditation, AI-driven chatbots, and video therapy sessions make platforms a preferred choice across age groups. As the digital mental health ecosystem matures, platform-based solutions continue to outpace device-centric models in user adoption and market presence.

The cognitive behavioral therapy (CBT) segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the cognitive behavioral therapy (CBT) segment is predicted to witness the highest growth rate, impelled by its proven clinical efficacy in treating anxiety, depression, and stress-related disorders. Digitally delivered CBT modules via apps and online platforms offer accessible, structured, and cost-effective treatment options. The rise of AI-powered CBT chatbots and self-guided programs has democratized access, particularly for patients in remote or underserved areas. As mental health literacy increases, demand for CBT-driven solutions continues to accelerate.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share, driven by rising mental health awareness, rapid urbanization, and strong smartphone penetration. Governments and private players across countries like China, India, and Japan are investing in telehealth infrastructure and digital wellness platforms. Cultural destigmatization of mental illness and increasing workplace mental health initiatives further contribute to adoption. The growing youth population and expanding digital ecosystems in the region are fostering rapid uptake of mental health apps and virtual therapy tools.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, attributed to advanced healthcare infrastructure, high mental health awareness, and supportive regulatory frameworks for digital therapeutics. The presence of leading mental health tech companies and a strong startup ecosystem accelerates innovation. Favorable reimbursement policies, government funding for tele-mental health, and increasing adoption by employers and insurers are contributing to rapid growth. Additionally, growing concerns around post-pandemic mental well-being continue to drive demand for digital mental health solutions in the region.

Key players in the market

Some of the key players in Emerging Mental Health Devices and Platforms Market include Acadia Healthcare, AbleTo Inc., Amelia Virtual Care, CareTech Holding PLC, Clarigent Health, Compass Pathways, Electromedical Products International (EPI), Eli Lilly and Co., Feel Therapeutics, Flow Neuroscience, Headspace Inc., Pear Therapeutics, Quartet Health, Spring Health, Talkspace Inc., Teladoc Health Inc. and Woebot Health.

Key Developments:

In June 2025, Acadia Healthcare expanded its digital mental health offerings in June 2025 by integrating new AI-powered therapy platforms for anxiety and depression management. These tools provide scalable remote patient engagement and real-time monitoring. Acadia also partnered with health insurers in the U.S. to improve reimbursement pathways.

In May 2025, AbleTo introduced expanded virtual care programs in May 2025 targeting chronic disease patients with co-morbid mental health conditions. The platform integrates evidence-based cognitive behavioral therapy (CBT) with personalized coaching, improving outcomes and reducing hospital readmissions.

In April 2025, Amelia Virtual Care launched an AI-driven chatbot in April 2025 to deliver 24/7 cognitive behavioral support and crisis intervention. The virtual assistant guides users through coping strategies and facilitates clinician escalation when needed.

Product Types Covered:

• Platforms
• Devices

Therapies Covered:

• Cognitive Behavioral Therapy (CBT)
• Electrotherapy
• Other Therapies

Age Groups Covered:

• Children/Adolescents
• Adults
• Seniors/Geriatric

Technologies Covered:

• Wearable Tech
• Mobile Apps
• Platforms & Telemedicine

Applications Covered:

• Self Management & Wellbeing
• Treatment
• Mental Health Assessment & Diagnosis
• Other Applications

End Users Covered:

• Patients
• Providers (Hospitals, Clinics)
• Employers
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 Technology Analysis
• 3.8 Application Analysis
• 3.9 End User Analysis
• 3.10 Emerging Markets
• 3.11 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Emerging Mental Health Devices and Platforms Market, By Product Type

• 5.1 Introduction
• 5.2 Platforms
• 5.3 Devices

6 Global Emerging Mental Health Devices and Platforms Market, By Therapy

• 6.1 Introduction
• 6.2 Cognitive Behavioral Therapy (CBT)
• 6.3 Electrotherapy
• 6.4 Other Therapies

7 Global Emerging Mental Health Devices and Platforms Market, By Age Group

• 7.1 Introduction
• 7.2 Children/Adolescents
• 7.3 Adults
• 7.4 Seniors/Geriatric

8 Global Emerging Mental Health Devices and Platforms Market, By Technology

• 8.1 Introduction
• 8.2 Wearable Tech
• 8.3 Mobile Apps
• 8.4 Platforms & Telemedicine

9 Global Emerging Mental Health Devices and Platforms Market, By Application

• 9.1 Introduction
• 9.2 Self Management & Wellbeing
• 9.3 Treatment
• 9.4 Mental Health Assessment & Diagnosis
  • 9.4.1 Stress
  • 9.4.2 Anxiety
  • 9.4.3 Depression
  • 9.4.4 Bipolar Disorder
• 9.5 Other Applications

10 Global Emerging Mental Health Devices and Platforms Market, By End User

• 10.1 Introduction
• 10.2 Patients
• 10.3 Providers (Hospitals, Clinics)
• 10.4 Employers
• 10.5 Other End Users

11 Global Emerging Mental Health Devices and Platforms Market, By Geography

• 11.1 Introduction
• 11.2 North America
  • 11.2.1 US
  • 11.2.2 Canada
  • 11.2.3 Mexico
• 11.3 Europe
  • 11.3.1 Germany
  • 11.3.2 UK
  • 11.3.3 Italy
  • 11.3.4 France
  • 11.3.5 Spain
  • 11.3.6 Rest of Europe
• 11.4 Asia Pacific
  • 11.4.1 Japan
  • 11.4.2 China
  • 11.4.3 India
  • 11.4.4 Australia
  • 11.4.5 New Zealand
  • 11.4.6 South Korea
  • 11.4.7 Rest of Asia Pacific
• 11.5 South America
  • 11.5.1 Argentina
  • 11.5.2 Brazil
  • 11.5.3 Chile
  • 11.5.4 Rest of South America
• 11.6 Middle East & Africa
  • 11.6.1 Saudi Arabia
  • 11.6.2 UAE
  • 11.6.3 Qatar
  • 11.6.4 South Africa
  • 11.6.5 Rest of Middle East & Africa

12 Key Developments

• 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 12.2 Acquisitions & Mergers
• 12.3 New Product Launch
• 12.4 Expansions
• 12.5 Other Key Strategies

13 Company Profiling

• 13.1 Acadia Healthcare
• 13.2 AbleTo Inc.
• 13.3 Amelia Virtual Care
• 13.4 CareTech Holding PLC
• 13.5 Clarigent Health
• 13.6 Compass Pathways
• 13.7 Electromedical Products International (EPI)
• 13.8 Eli Lilly and Co.
• 13.9 Feel Therapeutics
• 13.10 Flow Neuroscience
• 13.11 Headspace Inc.
• 13.12 Pear Therapeutics
• 13.13 Quartet Health
• 13.14 Spring Health
• 13.15 Talkspace Inc.
• 13.16 Teladoc Health Inc.
• 13.17 Woebot Health